— Know what they know.
Not Investment Advice
Also trades as: COEPW (NASDAQ) · $vol 0M

COEP NASDAQ

Coeptis Therapeutics Holdings, Inc.
1W: -9.9% 1M: -32.2% 3M: -5.0% YTD: -24.9% 1Y: +12.0% 3Y: -68.2% 5Y: -94.4%
$10.99
Last traded 2026-07-02 — delisted
NASDAQ · Technology · Software - Services · $38.6M mcap · 3M float · 1.74% daily turnover · Short 69% of daily vol

Balance Sheet Trends

Total Assets
$20M +122.7% ▲
5Y CAGR: +131.2%
Total Liabilities
$2M -58.6% ▼
5Y CAGR: -17.5%
Shareholders Equity
$17M +441.5% ▲
Cash & Investments
$6M +1091.8% ▲
5Y CAGR: +99.1%
Total Debt
$269K -80.8% ▼
5Y CAGR: -33.6%
Net Debt
-$5M -724.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$2M$4M$1M$533K$6M
Short-Term Investments$0$0$0$0$677K
Cash & ST Investments$2M$4M$1M$533K$6M
Net Receivables$0$8K$39K$0$7K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$2M$4M$2M$1M$7M
Property, Plant & Equip.$32K$71K$109K$60K$18K
Goodwill & Intangibles$0$4M$3M$542K$361K
Long-Term Investments$0$0$4M$6M$8M
Other Non-Current Assets$5M$348K$158K$2M$4M
Total Non-Current Assets$5M$4M$6M$8M$12M
Total Assets$7M$8M$8M$9M$20M
— Liabilities —
Accounts Payable$134K$99K$1M$1M$889K
Short-Term Debt$2M$2M$1M$1M$119K
Deferred Revenue$0$0$0$0$599K
Other Current Liabilities$0$182K$556K$1M$161K
Total Current Liabilities$3M$2M$3M$5M$2M
Long-Term Debt$2M$150K$150K$150K$150K
Other Non-Current Liab.$0$1M$557K$359K$168K
Total Non-Current Liabilities$2M$1M$768K$528K$318K
Total Liabilities$4M$3M$4M$5M$2M
— Equity —
Common Stock$4K$2K$4K$212$575
Retained Earnings-$28M-$66M-$87M-$98M-$110M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$2M$4M$4M$3M$17M
Total Liabilities & Equity$7M$8M$8M$9M$20M
— Key Metrics —
Total Debt$4M$2M$1M$1M$269K
Net Debt$2M-$2M-$245K$866K-$5M
Total Investments$0$0$4M$6M$9M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms